Affinity DataIC50: 0.550nMAssay Description:The compounds of the invention were screened in vitro for their ability to inhibit c-Met kinase activity. The IC50 values for the inhibition of c-Met...More data for this Ligand-Target Pair
Affinity DataIC50: 0.550nMAssay Description:The compounds of the invention were screened in vitro for their ability to inhibit c-Met kinase activity. The IC50 values for the inhibition of c-Met...More data for this Ligand-Target Pair
Affinity DataIC50: 0.550nMAssay Description:The compounds of the invention were screened in vitro for their ability to inhibit c-Met kinase activity. The IC50 values for the inhibition of c-Met...More data for this Ligand-Target Pair
Affinity DataIC50: 0.550nMAssay Description:The compounds of the invention were screened in vitro for their ability to inhibit c-Met kinase activity. The IC50 values for the inhibition of c-Met...More data for this Ligand-Target Pair
Affinity DataIC50: 0.550nMAssay Description:The compounds of the invention were screened in vitro for their ability to inhibit c-Met kinase activity. The IC50 values for the inhibition of c-Met...More data for this Ligand-Target Pair